Astec LifeSciences Limited has informed the Exchange regarding Appointment of Mr Mathew Eipe as Additional Director (Non-Executive & Independent Director) of the company w.e.f. April 13, 2026 upto Jung 6, 2027, subject to approval of the Shareholders.
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Astec LifeSciences announced major leadership changes on April 13, 2026. Chairman Mr. Nadir Godrej retired after reaching age 75, stepping down from both the chairmanship and directorship. Mr. Burjis N. Godrej resigned as Managing Director to focus on Godrej Agrovet Limited (parent company) and was reappointed as Non-Executive Director. Mr. Vishal Sharma from Godrej Industries Limited (ultimate holding company) was appointed as new Chairperson and Additional Director. Mr. Mathew Eipe was appointed as an Additional Independent Director for a term until June 6, 2027. Mr. Arijit Mukherjee was elevated to Executive Director & COO role. The board will now comprise 10 directors with 50% independent directors.
These are significant governance changes reflecting transition from the founding generation to next-level management within the Godrej group. The appointment of an experienced chemicals executive as chairperson and the elevation of internal talent to executive roles suggests continuity in operations. All appointments are subject to shareholder approval.